Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InnoCan Pharma C.INNO

Alternate Symbol(s):  INNPF

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The company's operations and research and development activities are based in Israel. Its business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: the research and development of CBD loaded exosomes; the research and development of the use of CBD loaded liposomes; and the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Innocan Pharma's Compassionate Care Treatment for Dogs

A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...read more

Innocan Pharma's Case Report Accepted

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased...read more

Inauguration of Its Drug Development Lab

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is...read more

Why this Canadian-Israeli Stock Grew 121% This Year

"Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale...read more

Distributers and investors

Our CEO Iris Bincovich reports back from Canada. She achieved: Meetings and soft commitments from distributers and investors and positivite feedbacks from pharma experts. More to follow soon via...read more

Successful Demonstration of Prolonged Release of CBD in Dogs

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is...read more

https://www.wallstreet-online.de/nachricht/14682875-innocan-

Innocan Pharma wird auf der Lift & Co. Expo am 19. November 2021 an einer Podiumsdiskussion zum Thema Unternehmenswachstum teilnehmen  rate and reply

innocan-pharma-noch-heimliche-star-exosomenforschung

https://www.wallstreet-online.de/nachricht/14671340-hot-stock-innocan-pharma-noch-heimliche-star-exosomenforschung  rate and reply

100% Exercise of Warrants Issued in December 2020 P.P.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 5, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan) is pleased to...read more

Via Twitter Iris Bincovic 4.11.2021

Labs Update: We are currently engaged in several clinical studies on animals. Following this step we will begin safety tests, that will ultimately lead us to clinical trials on humans. This is the...read more

Investor Gathering in Munich

Innocan Pharma CEO Iris Bincovich to Deliver a Speech at an Investor Gathering in Munich on October 29, 2021 NewsfileOct 28, 2021 2:00 AM EDT Herzliya, Israel and Calgary, Alberta-...read more

Shortpositions

Gem CEO.ca innocan haben wir zur Zeit ber 9 Mio STck short.  Die Shorties mssen sich wohl die nchsten Tagen eindekcen/zurckkaufen. Ich gehe mal davon aus, dass wir ber kurz wieder deutlich...read more

Investor Gathering in Munich

 Innocan Pharma CEO Iris Bincovich to Deliver a Speech at an Investor Gathering in Munich on October 29, 2021 @newsfile/innocan-pharma-ceo-iris-bincovich-to-deliver-a-speech  rate and reply

Closes C$8.2 Million Private Placement

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 13, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today...read more

C$8.2 Million Private Placement with Institutional Investors

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 8, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), today...read more

RE:Bitcoin at 55k.. LITT .03 about to explode. NFT's on fire

Scammer? I think so  rate and reply

Filing of a PCT Patent Application for its CBD Delivery Sys.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 4, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is...read more

Iris Bincovic über Twitter 24.09.2021

After a brilliant speeking session with our dear Scientific Advisory Board member Richard Serbin. I'm proud to share that we were approached by several sales and investment entities and this week...read more

Demonstrates a Prolonged Release of CBD in Large Animals

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is...read more

RE: Patent Application the Treatment & Prevention of Hairloss

nnoCan Pharma * (WKN: A2PSPW): There are several reasons for the share price to reach a new and possibly even previously unknown level very soon. So far, the cryptic announcements by InnoCan CEO...read more